CLINICAL_TRIALS
trial_result
· 2022-12-28
Clinical Trial Update: tAN to Mitigate Withdrawal Behaviors in Neonates [NA]
Summary
A completed clinical trial evaluating tAN to mitigate withdrawal behaviors in neonates with Neonatal Abstinence Syndrome; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Spark Biomedical, Inc. | Conditions: Neonatal Abstinence Syndrome | NA | Status: COMPLETED | Results posted: 2022-12-28